Nucleic Acid Therapy Accelerator

NATA is funded by the MRC to co-develop nucleic acid therapies (NATs) and associated technologies.It has built a translational platform for the development of ASO and siRNA therapies.

Category

  • Research programmes and networks

Functions

  • Advice or consultancy
  • Research and development

Similar organisations


Top collaborator categories

WordPress website theme by whoisAndyWhite